Clinical Research Directory
Browse clinical research sites, groups, and studies.
Clinical Impact of the IBox As an Early Intervention TooL
Sponsor: Predict4Health
Summary
International, multicentre, randomized 1:1 controlled trial to prove the clinical and medico economic benefits of the medical device Predigraft, by showing that the use of Predigraft could improve patient's follow-up.
Official title: Clinical Impact of the IBox As an Early Intervention TooL: a Prospective Randomised Controlled Trial to Assess the Use of a Software Predicting Allograft Survival in the Follow-up of Kidney Transplanted Patients.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
507
Start Date
2022-02-18
Completion Date
2025-02
Last Updated
2024-10-04
Healthy Volunteers
No
Conditions
Interventions
Predigraft
The Subject randomized to the Predigraft will benefit from Predigraft, a remote monitoring software that issues an alert to the investigator when the allograft survival prediction calculated by the iBox algorithm is decreasing. This follow-up is on top of the site's standard of care.
Locations (16)
Medizinische Universität Innsbruck
Innsbruck, Austria
Hôpital Saint-Louis
Paris, France, France
Hôpital Tenon
Paris, France, France
CHU Rangueil
Toulouse, France, France
Hôpital Necker
Paris, France
Universitätsklinikum Düsseldorf AÖR
Düsseldorf, Germany
Universitätsklinikum Hamburg-Eppendorf
Hamburg, Germany
Sourasky Medical Center - Ichilov Hospital
Tel Aviv, Israel
Hospital Del Mar - Parc de Salut Mar
Barcelona, Spain
Fundació Puigvert
Barcelona, Spain
Hospital Universitari i Politècnic La Fe
Valencia, Spain
Queen Elizabeth Hospital
Birmingham, United Kingdom
Leeds Teaching Hospital NHS Trust
Leeds, United Kingdom
Guy's & Saint Thomas' NHS Foundation Trust
London, United Kingdom
King's College Hospital
London, United Kingdom
Oxford Transplant Centre
Oxford, United Kingdom